IRE

OTHER4 trials

Sponsors

The University of Texas Health Science Center, Houston, Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery, Tianjin Medical University Cancer Institute and Hospital

Conditions

Hepatocellular CancerIREMetastatic Liver CancerUnresectable Pancreatic Cancer

Unknown Phase

Prospective Tumor Response Evaluation

TerminatedNCT02787954

The University of Texas Health Science Center, HoustonHepatocellular Cancer, Metastatic Liver Cancer

Start: 2016-01-31End: 2017-04-30Updated: 2018-10-18

Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer

Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryUnresectable Pancreatic Cancer

Start: 2019-05-01End: 2024-05-31Target: 30Updated: 2021-04-01

IRE After Chemotherapy for Locally Advanced Pancreatic Cancer

RecruitingNCT07799935

Tianjin Medical University Cancer Institute and HospitalIRE

Start: 2026-05-20End: 2027-12-31Target: 60Updated: 2026-09-02

IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus

RecruitingNCT07799922

Tianjin Medical University Cancer Institute and HospitalIRE

Start: 2026-05-20End: 2028-12-31Target: 60Updated: 2026-09-02